Insurance Coverage Desk

Unruptured Brain Aneurysm Cases Double in Two Decades

By 09/11/2026 1 min read 26 views
Unruptured Brain Aneurysm Cases Double in Two Decades - brain aneurysm
Connective-tissue disorders and autosomal dominant polycystic kidney disease (ADPKD) were associated with even higher rates, at 10.3% and 12.8%, respectively.

A systematic review published in The Lancet Neurology reveals that the prevalence of unruptured brain aneurysms has risen from 2.9% to 6.6% over the past two decades. Led by Judith Dremel of the University of Heidelberg, the study analyzed 162 studies involving 316,131 participants, finding that this increase cannot be fully attributed to population aging or improved imaging techniques.

Risk Factors Identified

The research identified several conditions linked to a higher prevalence of unruptured intracranial aneurysms (UIAs). Individuals with atherosclerosis had a prevalence of 5.5%, while those with a family history of aneurysms showed a rate of 7.9%. Connective-tissue disorders and autosomal dominant polycystic kidney disease (ADPKD) were associated with even higher rates, at 10.3% and 12.8%, respectively. Smoking and hypertension also significantly increased risk, with women facing a 1.9-fold higher risk than men.

Among healthy individuals undergoing imaging, the prevalence of UIAs rose from 5.0% in 2002–2015 to 6.6% in 2016–2022. Aneurysms measuring ≥5 mm doubled from 0.7% to 1.4% during this period. While the increase was consistent across countries, the study noted considerable variation between individual studies and low to moderate certainty of evidence.

Unidentified Factors and Screening Recommendations

Researchers suggest that environmental or other unknown factors may contribute to the rise in UIAs. The study’s limitations include its reliance on selected cohorts and cross-sectional studies, with findings on connective-tissue disorders potentially not applicable to all such conditions. They recommend targeted screening for high-risk groups, particularly those with ADPKD, a family history of aneurysms, or connective-tissue disorders, rather than routine screening for the general population.

Dremel and her team’s findings emphasize the need for further evaluation of personalized screening and management for high-risk groups.

Leave a Comment

Your email address will not be published. Required fields are marked *